Anti-Tissue Inhibitor of Metalloproteinase-2

Host: Mouse

Isotype: IgG1

Immunogen: native, human TIMP-2

Form: Liquid

Formulation: In 10 mM PBS, 0.2% BSA, pH 7.4.

Preservative: ≤0.1% sodium azide

Positive Control: Conditioned medium from dexamethasone-treated HT-1080 cells, melanoma A2058 cells, or bladder, breast, or ovarian carcinomas

Comments: Recognizes the ~21-28 kDa TIMP-2 protein conditioned medium from dexamethasone-treated HT1080 cells, melanoma, A2058 cells, and bladder, breast, and ovarian carcinoma.

Ref.: Cottam, D.W. and Rees, R.C. 1993. Intl. J. Oncol. 2, 861. Stetler-Stevenson, W.G., et al. 1993. FASEB J. 7, 1434. Woessner, J.F. 1991. FASEB J. 5, 2145. Liotta, L.A. and Stetler-Stevenson, W.G. 1990. In Seminars in Cancer Biology, ed. M.M. Gottesman. Vol. 1, 99.

Not available for sale in Japan.